AHSCT resets the immune system in highly active RRMS after high-efficacy drugs fail, delivering higher NEDA, fewer relapses, and durable function gains. When high-efficacy drugs stop holding relapsing ...

If a digital platform manipulates its algorithm rankings to favor its own products, consumers end up buying the same items at ...

Patients with cancer frequently receive broad-spectrum antibiotics, even if they are at low risk for antimicrobial-resistant infections.A computer prompt that notifies clinicians that a patient would ...

Adults living with Alzheimer’s-related dementia now have a second FDA-approved drug for agitation, and for the first time, ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...

The safety performance of autonomous vehicle (AV) algorithms is boosted by 90% using simulation data that better incorporates ...

By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than eight million deaths around the world every year. These are bacterial infections that resist ...

Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...

Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...

Once rapidly fatal, neglected, and orphan diseases without approved therapeutic options, systemic amyloidoses are now highly ...

Cancer therapy has dramatically changed over the past many decades, not only in efficacy but also complexity, with targeted ...